About this Journal Submit a Manuscript Table of Contents
ISRN Pharmaceutics
Volume 2012 (2012), Article ID 965280, 8 pages
http://dx.doi.org/10.5402/2012/965280
Research Article

Effect of Chemical Enhancers in Transdermal Permeation of Alfuzosin Hydrochloride

Department of Pharmaceutics, G. Pulla Reddy College of Pharmacy, Osmania University, Hyderabad, Andhra Pradesh 500 028, India

Received 30 October 2012; Accepted 20 November 2012

Academic Editors: H. Arima and C. Saturnino

Copyright © 2012 D. Prasanthi and P. K. Lakshmi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. C. Moffat, M. D. Osselton, B. Widdop, and J. Watts, Eds., Clarke's Analysis of Drugs and Poisons, Pharmaceutical Press, London, UK.
  2. A. C. Williams and B. W. Barry, “Penetration enhancers,” Advanced Drug Delivery Reviews, vol. 56, no. 5, pp. 603–618, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Karande and S. Mitragotri, “Enhancement of transdermal drug delivery via synergistic action of chemicals,” Biochimica et Biophysica Acta, vol. 1788, no. 11, pp. 2362–2373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Karande, A. Jain, K. Ergun, V. Kispersky, and S. Mitragotri, “Design principles of chemical penetration enhancers for transdermal drug delivery,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 13, pp. 4688–4693, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. B. W. Barry, “Breaching the skin's barrier to drugs,” Nature Biotechnology, vol. 22, no. 2, pp. 165–167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. B. W. Barry, “Lipid-protein-partitioning theory of skin penetration enhancement,” Journal of Controlled Release, vol. 15, no. 3, pp. 237–248, 1991. View at Scopus
  7. N. Buyuktimkin, S. Buyuktimkin, and J. H. Rytting, “Chemical means of transdermal drug permeation enhancement,” in Transdermal and Topical Drug Delivery Systems, T. K. Ghosh, W. R. Pfister, and S. Yum, Eds., Informa Health Care, 1997.
  8. A. Arellano, S. Santoyo, C. Martín, and P. Ygartua, “Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels,” European Journal of Pharmaceutical Sciences, vol. 7, no. 2, pp. 129–135, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. J. D. Michael, Dermal Toxicology. Toxicologist's Pocket Handbook, CRC Press, 2000.
  10. C. Ren, L. Fang, T. Li, M. Wang, L. Zhao, and Z. He, “Effect of permeation enhancers and organic acids on the skin permeation of indapamide,” International Journal of Pharmaceutics, vol. 350, no. 1-2, pp. 43–47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Jantharaprapap and G. Stagni, “Effects of penetration enhancers on in vitro permeability of meloxicam gels,” International Journal of Pharmaceutics, vol. 343, no. 1-2, pp. 26–33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Santoyo and P. Ygartua, “Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 2, pp. 245–250, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Loth, “Vehicular influence on transdermal drug penetration,” International Journal of Pharmaceutics, vol. 68, no. 1-3, pp. 1–10, 1991. View at Scopus
  14. K. Sato, K. Sugibayashi, and Y. Morimoto, “Effect and mode of action of aliphatic esters on the in vitro skin permeation of nicorandil,” International Journal of Pharmaceutics, vol. 43, no. 1-2, pp. 31–40, 1988. View at Scopus
  15. S. N. Murthy, A. Sen, and S. W. Hui, “Surfactant-enhanced transdermal delivery by electroporation,” Journal of Controlled Release, vol. 98, no. 2, pp. 307–315, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Mura, M. T. Faucci, G. Bramanti, and P. Corti, “Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations,” European Journal of Pharmaceutical Sciences, vol. 9, no. 4, pp. 365–372, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. H. O. Ammar, M. Ghorab, S. A. El-Nahhas, and R. Kamel, “Design of a transdermal delivery system for aspirin as an antithrombotic drug,” International Journal of Pharmaceutics, vol. 327, no. 1-2, pp. 81–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. V. S. N. M. Dwibhashyam and J. Vijaya Ratna, “Chemical penetration enhancers—an update,” Indian Drugs, vol. 47, no. 4, pp. 5–18, 2010. View at Scopus
  19. A. N. C. Anigbogu, A. C. Williams, B. W. Barry, and H. G. M. Edwards, “Fourier transform Raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum,” International Journal of Pharmaceutics, vol. 125, no. 2, pp. 265–282, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. P. J. Lee, R. Langer, and V. P. Shastri, “Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport,” Journal of Pharmaceutical Sciences, vol. 94, no. 4, pp. 912–917, 2005. View at Publisher · View at Google Scholar · View at Scopus